Mesosil develops and manufactures antimicrobial and bioactive additives for dental and medical materials.
Mesosil’s innovative silica-based platform enables high-capacity delivery and sustained release of bioactive agents, addressing critical challenges in infection prevention and biomaterial longevity. In dental materials, our technology reduces recurrent tooth decay by up to 80%. With applications in orthopedics, implantable devices, and other medical fields currently under evaluation, Mesosil is creating the next generation of long-term antimicrobial protection. Our platform seamlessly integrates into existing manufacturing and clinical workflows, offering a scalable, high-impact solution for the future of medical materials.

Mesosil

The office at 124 Edward St serves as the strategic hub for executive leadership and board governance in Toronto.

Mesosil

Org chart

Teams

Offices

Mesosil

Org chart

Teams

Offices

Related companies